A Phase Ⅲ Clinical Trial of Recombinant COVID-19 Trivalent (XBB+BA.5+Delta) Protein Vaccine (Sf9 Cell) in Booster Vaccination

Name: A Phase Ⅲ Clinical Trial of Recombinant COVID-19 Trivalent (XBB+BA.5+Delta) Protein Vaccine (Sf9 Cell) in Booster Vaccination
License: Public Domain

WestVac Biopharma Co., Ltd.

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

covid

covid-19

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 300299
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.